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Abstract 
Introduction: Human Papillomavirus (HPV) causes 32,500 new cancers and roughly 14 million 
new infections annually in the United States.  These cancers include cervical, oropharyngeal, 
anal, vaginal, vulvar, penile cancers and genital warts (Centers for Disease Control and 
Prevention (CDC), 2015). While the HPV vaccine was approved in 2006, HPV vaccination rates 
are not progressing as planned toward the Healthy People 2020 goal of 80% coverage, with Ohio 
rates in the 50-59% range.  
Purpose: The purpose of this project is to identify HPV immunization initiation rates and to 
implement a communication strategy to improve rates for adolescent patients.   
Methods: This DNP project pilot tested an evidence-based provider communication intervention 
with goal of improving HPV vaccination rates in an adolescent population, 11-18 years of age.  
Impact of the educational intervention was evaluated by comparing pre-intervention and post-
intervention HPV vaccination rates in a Midwest pediatric primary care practice.   
Results: A total of 1024 total patient records identified both pre-intervention and post-
intervention that met inclusion criteria.  Between the four providers, the total patient counts 
ranged from 108 to 610. Pre-intervention vaccination rates ranged from 44.43% to 59.30%.  
Post-intervention vaccination rates ranged from 47.86% to 62.78%.  The change in satisfaction 
increased across all providers ranging from 3.71% to 8.60%   
Conclusions:  The intervention was found to be a cost-effective and time-sensitive intervention 
to promote improved HPV vaccination rates. Overall, the average rate increased from 49.31% to 
53.01% 
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Section One: Nature of the Problem 
1. Introduction to the Problem 
 Human Papillomavirus (HPV) causes 32,500 new cancers and roughly 14 million new 
infections annually in the United States.  These cancers include cervical, oropharyngeal, anal, 
vaginal, vulvar, penile cancers and genital warts (Centers for Disease Control and Prevention 
(CDC), 2015); CDC, 2018).  HPV vaccination prevents cervical cancer, uncomfortable testing 
and treatment, and can prevent cancers of the oropharynx and anus/rectum where there is no 
cancer screening tests (CDC, 2018).  Worldwide, HPV infection is responsible for one-half 
million cases of cancer and more than 250,000 deaths every year (White, 2014).  
 In 2006, the HPV vaccine was approved by the FDA to prevent contracting the human 
papillomavirus types that cause cancers and genital warts was recommended by the Advisory 
Committee on Immunization Practices (ACIP) for regular use in females in 2006 and males in 
2011. More than a decade later, vaccination rates remain below the goal of Healthy People 2020 
of 80% coverage of the population, with only 50% of females and 38% of males having 
completed the HPV vaccination series.  Adolescents may receive the HPV vaccination at the 
same visit as Tdap and meningococcal vaccine yet often do not. The result is an almost 100% 
effective cancer prevention and HPV-related disease vaccine goes unused in a large part of the 
population. Understanding parents’ concerns and provider communication behaviors with 
patients and families, effective interventions can be created to increase HPV vaccination rates. 
(Cates, et al., 2018).  
The HPV vaccine is recommended by the CDC for both males and females.  Commonly 
administered at 11 or 12 years of age, it can be given at 9 years through 26 years of age (CDC, 
2016).  The U.S. Department of Health and Human Services report (2015) that HPV vaccination 
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rates are not progressing as planned toward the Healthy People 2020 goal of 80% coverage 
(Gilkey et al., 2015). The CDC (2017a) report 50-59% HPV vaccination rates for the state of 
Ohio and national coverage at 60% were reported for 2016-2017.  These rates are below the goal 
rate of 80%. Reported contributing factors to under-utilization of the HPV vaccine include cost, 
lack of access to primary care, inaccurate information in the media, negative parental attitudes 
regarding general vaccinations.  Ethical issues surrounding the HPV vaccination include whether 
the vaccine increases the early onset of sexual activity and whether to vaccinate people who have 
opted to abstain from sex.  These questions extend to the manufacturers of the HPV vaccines as 
well, regarding the safety and efficacy of the vaccine and the need for research to continue the 
cycle of improved, viable products (White, 2014).  Health policy issues which have focused on 
attempts to use policy changes to increase HPV vaccination rates, such as compulsory HPV 
vaccination for school entry, have proved unsuccessful and ineffectual (Dempsey et al., 2018).  
Research suggests that improving health care provider communication behaviors is crucial to 
increase HPV vaccination rates, especially in primary care, where the majority of HPV vaccines 
are given (Gilkey et al., 2015).   
 Parental concerns about vaccine safety, efficacy and insufficient research when 
promoting the HPV vaccination to patients and their families are of interest to pediatric primary 
health care providers.  Addressing the negative attitudes about HPV vaccination outcomes 
secondary to the dissemination of inaccurate information from social media and lack of support 
from significant others are ongoing struggles for the pediatric primary care provider.  The need to 
be properly prepared to respond to the misinformation, information deficits, and overall lack of 
HPV vaccination knowledge is required to reach the Healthy People 2020 goal of 80% coverage 
(Zimet, et al., 2013).   
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2. Purpose of project 
     The purpose of this project is to identify HPV immunization initiation rates and to implement 
a communication strategy to improve rates for adolescent patients.  To implement this project, 
internal HPV immunization rates were assessed in a Midwest primary care pediatric practice for 
four health care providers (2 physicians and 2 nurse practitioners). These findings were used to 
inform the development of quality improvement communication strategies to increase HPV 
vaccination rates.  The population of interest is male and female adolescents ages 11 to 18 years.    
 This DNP project serves as pilot testing of a provider-focused educational intervention to 
improve provider communication strategies to increase HPV vaccination rates in adolescents 11 
to 18 years in a private pediatric practice.  
Section Two: Review of the Literature 
1. Clinical Practice Problem Statement.  
With the HPV vaccine being most effective prior to sexual activity and possible  
 exposure, it is crucial to examine the influence of health care provider communication with  
patients and families when recommending the HPV vaccine (Perkins, et al., 2014).  To locate the 
related external evidence, the following PICOT question was generated.   
P (patient population): In pediatric patients    
I (Issue of interest): how does the content and delivery of provider communication about  
            HPV vaccines  
C (Comparison Intervention or Issue of interest) compared to no provider communication 
O (Outcome): impact HPV immunization initiation rates      
T (Time): over a 6 week period?  
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2. Evaluation and Summary of the Evidence in the Literature 
 In the pediatric population, optimal administration of the vaccine is prior to possible HPV 
 exposure through sexual activity, ages 9 to 14 years of age (CDC, 2015).  The goal of the HPV 
vaccine is to lower HPV related cancers and their sequelae to those most vulnerable (Gostin,  
2011). As internal immunization rates were examined, evidence demonstrated that provider 
recommendations and communication behaviors consistently influence compliance in 
adolescents receiving the HPV vaccination (CDC, 2015).  Other factors influencing health care 
provider communication is the environment in which the information is being shared, support 
staff, and the time allowed to answer patient questions and discuss the HPV vaccination with 
patients and their families (Dempsey et al., 2018).   
 When communication best practices are not identified and made consistent across health 
care providers, results include missed immunization opportunities, placing pediatric patient’s 
health at risk unnecessarily and a possible increase in HPV-related cancers (Perkins, et al., 2014). 
Colleagues, peers, and health care providers should advocate for best practice communication 
guidelines for disease prevention, mental and health anguish avoidance, and the expense of HPV 
related disease treatment (CDC, 2015). 
A literature review was conducted using CINAHL, PubMed, PsycINFO, and EBSCO  
Host databases to find information on HPV vaccination provider communication for publication  
years 2008-2018, as approval by the U.S Food and Drug Administration (FDA) for HPV vaccine 
was 2006.  An internet search was also completed to locate additional information from 
government resources and reliable organizations.  Search terms included: provider  
communication, HPV communication, human papilloma vaccination, HPV vaccine education,  
HPV vaccination and quality improvement, provider communication and time allowed, and  
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provider education.  See appendix A for the evaluation table of the external evidence. .  
3. Critical Appraisal of the Evidence 
 A synthesis of the literature included random controlled trials, qualitative  
and descriptive studies, cross-sectional surveys, meta-analyses, mixed methods, and literature 
reviews.  Most of the research articles addressed the relationship between provider  
communication and HPV vaccination uptake.  There was some variance in interventions  
combined with communication training, as Dempsey, et al. (2018) utilized information sheets, a  
parental education website, and disease images; Rand, et al. (2018) included performance  
feedback and learning collaborative calls; Perkins, et al. (2015) employed quality improvement  
incentives, repeated contacts, and individualized feedback; Sussman, et al. (2015) utilized social  
media and health system improvements; and Groom, et al. (2017) included an education session  
on HPV information, system-wide assessment and feedback, and facility-specific coverage data  
respectively.  The evidence indicated that provider communication was an influential factor that 
increased HPV vaccination opportunities and rates.   
 Ten of the nineteen studies appraised noted that strong, high-quality health care provider 
professional recommendations increased HPV vaccine administration.  Five of the nineteen 
studies appraised indicated that the greater health care provider knowledge base was about HPV 
disease, the HPV vaccine, and current guidelines, this increased knowledge was associated with 
higher rates of HPV vaccination initiation and completion.  The research also overwhelmingly 
agreed that an intervention developed for improved provider communication was needed to 
achieve higher HPV vaccination rates that were sustainable (Dempsey, et al., 2018; Rand, et al., 
2018; Clark, et al., 2016; Sussman, et al., 2015; Cates, et al., 2018; Fairbrother, et al., 2013; 
McRee and Gilkey, 2014; Moss, et al., 2016; Gilkey, et al., 2015; Gilkey, et al., 2016; Smith, et 
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al., 2016; Finney, et al., 2017; Perkins, et al., 2015; Kornides, et al., 2018; Groom, et al., 2017; 
Reno, et al., 2018).   
Gaps in Evidence 
 Gaps that influence communication strategies include patient demographics, socio-
economic levels, and level of education.  More research is needed about the influence of health 
care provider self-reporting overestimation for vaccine support and on the effects of health care 
provider incentives for vaccine recommendation.  Additionally, the role of parents’ 
communication satisfaction, the role of provider recommendation quality, vaccine confidence, 
and parent-provider relationship quality are areas that need further research investigation 
(Kornides, 2018).  While these may play a role in HPV vaccination uptake, the focus for this 
project was provider education.   
4. Presentation of the Theoretical Basis 
 Pender Health Promotion Model (Appendix B) 
 The Pender Health Promotion Model (HPM) is an appropriate framework for this  
project as it focuses on three areas: individual characteristics and experiences, behavior-specific  
cognitions and affect, and behavioral outcomes. Two of the assumptions of the HPM also 
compliment the importance of communication: health care providers are a part of a 
patient’s interpersonal environment that influences people and self-initiated reconfiguration 
is essential to changing behavior.  Furthermore, of the theoretical statements derived from the  
HPM: persons commit to engaging in behaviors they perceive a benefit and persons can modify 
thoughts, affect and the interpersonal and physical environment to create incentives for health 
actions are also pertinent to improved HPV vaccination communication (Petripin, 2016).   
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 The role of communication by health care providers is vital to vaccination rates for 
multiple reasons.  Children do not get the HPV vaccine if patients and families do not know the 
value of the vaccines in disease prevention.  In addition, vaccination initiation timing, the 
recommended vaccination schedule and understanding of the vaccine details is neglected when 
patients and families are not afforded the time to ask questions (Waisbord and Larson, 2005). 
Pender’s Health Promotion Model is applicable in understanding behavior-specific cognitions 
and affect influence the communication strategies health care providers utilize. The HPM 
recognizes the importance and influence health care providers possess on patient decisions, 
including those to vaccinate.  Lastly, the HPM is relevant in perceived benefit of both the health 
care provider and patient.  Patients will commit to vaccination if they perceive the benefit 
communicated by the health care provider.  Health care providers will commit to a behavior 
change in communication strategies when they, as well understand the perceived benefit of 
increased HPV vaccination rates (Petripin, 2016).   
Evidence-Based Practice Model: IOWA (Appendix C) 
 The Iowa Model of Evidence-Based Practice to Promote Quality provides specific steps 
for implementing evidence-based practice change.  The Iowa model begins by identifying 
“triggers” or practice questions through recognition of a clinical problem.  The trigger for this 
project is the lagging HPV vaccination rates and stagnant progress towards the desired 80% 
coverage goal from the Department of Health and Human Services (2015) report Healthy People 
2020.  The next step in the Iowa model is determining if the clinical problem is a priority and a 
clinically relevant practice question that can be tackled using the EBP process.  Improving HPV 
vaccination rates in the adolescent population is a priority for the clinical setting for this project, 
the state of Ohio, and nationally.  National HPV vaccination coverage is 60% and the state of 
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Ohio is 50-59% on average for initiation rates.  Nationally 49% of adolescents were up-to-date 
on the HPV vaccine, 40-49% for the state of Ohio respectfully for completion rates (CDC, 2017). 
A team was formed and was comprised of stakeholders, including APRNs, physicians, staff, and 
organizational leaders.  The evidence was reviewed, synthesized, and evaluated.  Using the 
evidence, a provider education intervention was developed and piloted in practice, selecting 
patient health outcomes, collecting baseline data, designing evidence-based guidelines, 
evaluating the process, and modifying practice guidelines accordingly. 
In this project, the intervention in the form of a provider communication education 
session combining information on HPV disease, HPV vaccination, parental communication 
strategies, high-quality recommendation verbiage, and emphasizing cancer prevention is pilot 
tested.   
Following the pilot, a determination is made regarding the effectiveness and 
appropriateness and a decision to implement or modify the interventional provider 
communication education session. If the education session results in improved outcomes such as 
increased HPV vaccination rates, then the integration into clinical practice would be facilitated 
by leadership, education support, and ongoing monitoring of outcomes.   
The provider communication education session would also consider the environment and 
time allotted, clinician and staff feedback, cost-effectiveness, and the acceptance of information 
by patients and families, with HPV vaccination rate increases reflecting outcome success.  
Lastly, dissemination of project findings would be shared through clinical site presentation and 
publication, supporting the growth of EBP culture and the spirit of inquiry (Melnyk and Fineout-
Overholt, 2015).  
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This project used the internal evidence collected in a real world clinical setting, 
supporting the literature that HPV vaccination rate uptake is not satisfactory and a provider 
communication intervention is a sound means to increase HPV vaccination rates (Dempsey, et 
al., 2018; Hudson, et al., 2016; Rand, et al., 2018; Clark, et al., 2016; Sussman, et al., 2015; 
Fairbrother, et al., 2013; McRee and Gilkey, 2014; Zimet, 2013; Moss, 2016; Smith, et al., 2016; 
Finney, et al., 2017; Perkins, et al., 2015; Kornides, et al., 2018; Reno, et al., 2018).  
Utility/Feasibility: Approach to Improve Communication Best Practices 
  Educating health care providers about the methods to approach, articulate, and advocate  
 for the administration of the HPV vaccination to achieve the highest immunization rates based 
 on evidence-based practice rules that can be guided by both Pender’s Health Promotion Model  
and IOWA Model is the overall quality practice change goal. The primary care office setting was 
an appropriate site as research suggests this is where the majority of adolescents are receiving 
their HPV vaccinations (Gilkey, et al., 2015).   Collecting internal evidence that is occurring in a 
real-life clinical setting does not put human subjects at risk because HPV vaccination rates are 
created automatically through the quality tab in the patient’s electronic chart for that age group  
parameter.  Athenanet, the electronic charting system, can create quality management reports  
where patient data is not identified, age range specific, and are unique to each provider using the 
 updated vaccine recommendations by the Advisory Committee on Immunization Practices  
(ACIP).  This project met the criteria for exemption from institutional review board oversight 
due to the quality improvement focus. The development of a provider communication  
session, using evidence-based research quality improvement communication strategies is fitting 
to achieve higher, sustainable HPV vaccination rates (Dempsey, et al., 2018; Rand, et al., 2018; 
Clark, et al., 2016; Sussman, et al., 2015; Cates, et al., 2018; Fairbrother, et al., 2013; McRee and 
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Gilkey, 2014; Moss, et al., 2016; Gilkey, et al., 2015; Gilkey, et al., 2016; Smith, et al., 2016; 
Finney, et al., 2017; Perkins, et al., 2015; Kornides, et al., 2018; Groom, et al., 2017; Reno, et al., 
2018). In regards to clinical feasibility, a provider communication education session is a cost-
efficient intervention that can be done in office, flexible to the provider’s schedule.  The session 
would an hour, respecting clinical patient care obligations.  In promotion of the provider 
communication education session, the healthcare organization would be committed to the 
success of the intervention, supporting the desired outcome of improved HPV vaccination rates. 
See Appendix D for the provider educational intervention content.   
 The benefits of the provider communication education session are far reaching when  
considering the increased uptake of HPV vaccination rates.  Public health benefits include the  
reduction of HPV disease and HPV-related cancers and reduced pediatric health risk.  
Additionally, the mental and health anguish that is associated with HPV cancer sequelae and  
treatment would be avoided.  HPV-related disease treatment costs would also experience a  
reduction with increased HPV vaccination rates (Perkins, et al., 2014; CDC, 2015).  The 
only notable risk is that the providers are not vested in the HPV vaccination rate change  
 communication education session, depleting the necessary buy in to promote the HPV  
vaccination for uptake improvements.  
 When implementing the provider communication education session, budgetary 
concerns are minimal.  If implemented around the provider clinical schedule, there will be  
no loss of income from reduced patient care. The education session itself, is an hour long 
verbal/PowerPoint presentation and discussion with no added operational cost and can be 
provided in provider’s office space.   
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Evaluation 
 In this pilot project, the provider communication education session implemented was  
 evaluated by comparing HPV vaccination rates for 6 weeks prior to session implementation 
compared to the rates 6 weeks after implementation.  Quality measure reports were generated to 
examine HPV vaccination rates (%) for each provider using the age parameters of 11 to 18 years 
of age.  Health status impact can be identified through the benefits of vaccination.  Merits reach 
beyond the direct prevention of HPV disease, extending protection across the life course, prevent 
outcomes in communities, stabilize health care systems, promote health care equity, and lessen 
the burden for local and national economies (Wilder-Smith, et al., 2017; Durham, et al., 2016).      
5. Recommendations Summary 
 The focus of this project was to evaluate the impact of an evidence-based, provider-
focused communication strategy on HPV vaccination rates in adolescents, 11 to 18 years in age.  
Steps to evaluate the outcome of improved HPV vaccination rates.  Outcomes were evaluated by 
comparing  internal HPV immunization initiation rates in a private pediatric primary care 
practice comprised of four health care providers for 6 weeks prior to and 6 weeks following the 
provider education intervention to promote evidence-based communication strategies with 
patients and parents regarding HPV vaccinations.  The evidence that is collected is vital as it 
relates to the Department of Health and Human Services report (2015) of HPV vaccination rates 
not progressing as planned toward the Healthy People 2020 goal of 80% coverage (Gilkey, et al., 
2015).  This project reflects the internal evidence collected in a real life clinical setting, 
supporting the literature review that HPV vaccination rates are not progressing toward national 
goals and a provider communication education session is one intervention, driven by evidence, 
that can increase HPV vaccination rates (Dempsey, et al., 2018; Hudson, et al., 2016; Rand, et 
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al., 2018; Clark, et al., 2016; Sussman, et al., 2015; Fairbrother, et al., 2013; McRee and Gilkey, 
2014; Zimet, 2013; Moss, 2016; Smith, et al., 2016; Finney, et al., 2017; Perkins, et al., 2015; 
Kornides, et al., 2018; Reno, et al., 2018).  Increased HPV vaccination rates will reduce HPV-
related cancers and death worldwide, thus improving population patient health outcomes and 
quality of care, local and state economies and health care costs, and stabilization of healthy 
systems (Perkins, et al.,2014; CDC, 2015; Wilder-Smith, et al., 2017). 
 Stakeholders in this quality improvement pilot include the Advanced Practice Nurses 
(APRNs) and physicians recommending the vaccine, as well as the patients and families that are 
receiving the vaccine information.  Engagement of stakeholders will be approached by providing 
the APRNs and physicians with their individual HPV vaccination rates.  The need for 
communication was understood when the provider vaccination rate is noted as subpar according 
to the desired Healthy People 2020 80% rate (Gilkey, et al., 2015).  Potential barriers for a 
provider communication education session include time and varying schedules, perceived 
benefit, and personal views of HPV vaccination (Gilkey, et al., 2015).  Time and varying 
schedules may be addressed by providing the education session at the clinical practice site at 
lunch when offices are typically closed, making it convenient for the health care provider.  
Perceived benefit and personal views are more difficult to address, however, providing factual 
information regarding the efficacy and widespread acceptance of the HPV vaccination, in 
addition to the determined Healthy People 2020 goals for HPV vaccination rates would be 
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Section Three: Methods 
1. Recommendations for implementation of practice change 
 Per the CDC, the HPV vaccine is recommended for adolescents of both genders between 
the ages of 11 and 14, with an age range of 9 to 26 years of age.  Based on the evidence acquired, 
reviewed, and evaluated, it is recommended that a provider communication education session be 
implemented as an intervention to increase HPV immunization rates.  The provider 
communication education session based on evidence should integrate information on HPV 
disease, HPV vaccination, parental communication strategies, high-quality recommendation 
verbiage, and an emphasis on cancer prevention.   
Plan for implementation of the EBP practice change 
 From the evidence-based recommendations, the strategy of implementing a provider 
communication education session that encompasses the need for information on HPV disease, 
prevalence, and sequelae, HPV vaccination current rate for Ohio, the United States and the 
health care provider participating, and effective methods for communicating with parents,  
including high-quality recommendation verbiage, and emphasizing cancer prevention.  This  
project will include the development and implementation of a provider communication education 
session for data collection to evaluate initiation vaccination rate trends, with consideration given 
to time constraints. The clinical agency served as the provider communication education session 
setting, in addition to serving as the specific practice for the collection of internal HPV 
immunization initiation rate evidence for four health care providers, using the evidential findings 
for the development of strategies to improve HPV vaccination rates. 
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Sample, Practice Setting, Clinical Context Description, Patient preferences 
 The focus patient population being reviewed for HPV vaccination initiation rates was 
pediatric patients, ages 11 to 18 years. This age range was selected because HPV vaccines are 
recommended and administered at 11 years old clinically with the Tdap and meningococcal 
before 7th grade entrance. HPV vaccination initiation rates were analyzed for 6 weeks prior to the 
provider education intervention to gather pre-intervention baseline data; and analyzed for pilot 
testing of the communication strategy and for 6 week following the intervention to determine an 
impact of the intervention.  The pre- and post-vaccination rates provide quality improvement 
data to assess initial and ongoing the potential impact of the provider communication-strategy 
education on patient outcomes. The practice and clinician-specific vaccination rates included two 
pediatric physicians and two pediatric nurse practitioners in a private pediatric primary care 
setting.  The pediatric population serviced in this pediatric primary care office are 50% 
Caresource/Medicaid (state insurance) and 50% private insurance.  This practice setting and 
patient population are comparable to those described in the literature.  The pediatric primary care 
office was an appropriate setting secondary to the patient population, inclusion of both 
physicians and nurse practitioners vaccination rates, and the fact that the majority of HPV 
vaccines are given in primary care (Gilkey, et al., 2015).  
Readiness for Change 
  This pediatric primary care office is vested in this project because of project manager’s 
status as a provider in the practice and by reason of understanding the importance for quality 
measures and patient health in regards to the HPV vaccination.  This practice is ready and open 
to adopt strategies to improve provider HPV vaccination rates based on research and evidence 
based findings.    
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Procedure for Practice Change  
 A provider-communication education pilot session was developed and implemented using 
evidence based strategies that combine information on HPV disease, HPV vaccination, parental 
communication tactics, high-quality verbiage, and cancer prevention.  See Appendix D for the 
provider educational intervention content. Following the pilot, the effectiveness and 
appropriateness of the intervention will determine if the education session needs modified. To 
evaluate the impact of the pilot communication strategy on the patient-centered HPV vaccination 
initiation rates, data were collected for 6 weeks prior to implementation of the provider education 
intervention and for 6 weeks post-communication intervention.    
 Potential barriers include provider time and varying work schedules, provider buy-in, and 
personal bias.  Time and work schedule variances can be addressed through education session 
presentation flexibility to avoid conflict with patient appointments.  Provider buy in and personal 
bias can be addressed through providing factual information on the efficacy and acceptance of  
the HPV vaccination, the Healthy People 2020 HPV vaccination goal, and the immediate and  
long-term benefits of the HPV vaccination (DaRosa, et al., 2011; Gilkey, et. al., 2015). 
 Potential facilitators include leadership and administrative support, minimal budgetary  
concerns, minimal time for implementation, responsive data gathering and analysis, and 
evidence-based HPV vaccination findings.  Leadership and administrative support is key to 
access statistical information and quality indicators, as well as additional endorsement  
for providers to take into consideration the information being provided in the education session. 
Minimal budgetary concerns and supplies are advantages to the organization and practice as cost- 
effective.  Evidence-based HPV vaccination findings confirm the value of a provider  
communication education session as a means to increase HPV vaccination rates (Dempsey, et al.,  
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2018; Hudson, et al., 2016; Rand, et al., 2018; Clark, et al., 2016; Sussman, et al., 2015; 
Fairbrother, et al., 2013; McRee and Gilkey, 2014; Zimet, 2013; Moss, 2016; Smith et al., 2016; 
Finney, et al., 2017; Perkins, et al., 2015; Kornides, et al., 2018; Reno, et al., 2018). 
Measurement methods/tools 
The objectives for this project were met using the following procedures:   
 Collection of HPV vaccination initiation rates for the specific pediatric primary care 
practice (6 weeks prior to communication strategy pilot test and 6 weeks post 
communication strategy pilot test); 
 Collection of HPV vaccination standards for the project specific pediatric  
primary care practice, as well as state and national vaccination standards;  
 Application of quality indicators for improvement strategy development;  
 Description of a comprehensive communication strategy description based on published, 
evidence-based literature.   
This DNP project pilot tested a provider communication intervention, evaluating impact by 
comparing pre-intervention and post-intervention HPV vaccination rates in a Midwest pediatric 
primary care practice.  
Collecting internal evidence of the pre-implementation 6 week provider immunization 
initiation rates and post-implementation 6 week immunization initiation rates will be 
accomplished using the already in place electronic charting system, Athenanet in the primary 
care office.  Athenanet can create quality management reports that do not identify patient data, 
are age-range and time-range specific, and are exclusive to that provider using the updated 
vaccine recommendations by the Advisory Committee on Immunization Practices (ACIP).   
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Data collection process/Data analysis 
 A Quality Management Report (QMR) is a tool that allows a user to create reports by  
quality measure and program, provider, and specialty.  The report can be used to benchmark  
provider performance internally or against external performance targets.  The QMR is built off  
the Quality Management Engine (QME) which is a rules engine that continuously evaluates  
patient data to determine if a quality measure has been satisfied.  The provider performance rate 
is a percentage over the patient population, time period, and age parameters selected.  Reports  
were run to ascertain HPV vaccination rate performance including HPV vaccination initiation 
rates across multiple providers and as the practice as a whole to make decisions on quality 
improvement initiatives.    
 HPV vaccination initiation provider rates were gathered for 6 weeks before and after 
implementation of the provider education session on HPV communication strategies.  Due to 
time constraints of the project, continued data collection and analyses beyond the timeframe of 
the current project will be performed for future evaluation to best ascertain the provider 
vaccination rate data and trends.  According to the US Preventative Services Task Force (2017), 
attempts to quantify the magnitude of benefit from implementing a primary care preventative 
service may take years to achieve. Thus, yearly attempts to quantify progress in immunization 
rates is planned.  
Practice model use analysis 
 The Iowa Model of Evidence-Based Practice to Promote Quality provides guidance when 
making decisions about administrative and clinical practices that affect patient health outcomes 
(Titler, et al., 2001). This model can be applied to the implementation and dissemination of this 
project through the piloting of the provider communication education session.  Before and after 
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the provider communication education session is completed, provider vaccination rates would be 
examined to evaluate the process and desired outcomes.  If, as the literature supports, the 
communication education session increases vaccine uptake, this education session can be 
adopted into practice and results disseminated to help other providers increase their vaccination 
rates.   
Proposed budget, time, and resources plan 
 Expenditures were minimal for this pilot project due to support of the practice.  Practice 
support included coverage of the education time for presentation preparation and delivery.  The 
only expenses were color copying for 4 copies of the presentation ($17.80) and rental of a 
portable projection screen ($53.57).  
 The timeline of the project occurred over the 4th quarter of 2018 and the first quarter of 
2019.   The project used the Athenanet Quality Management System to generate vaccination 
initiation rate reports before and after pilot implementation of the provider communication 
strategy.  The use of the Athenanet Quality Management System required continued support from 
leadership.  Other resources included a meeting place (i.e., office lunch room) for presentation 
and the providers receiving the communication education session.  
Section Four: Findings 
1. Results 
 Based on evidence obtained, assessed, and evaluated, a provider communication  
education session was implemented as an intervention to increase HPV immunization rates in a  
pediatric primary care office. The provider communication education session was presented to 
four pediatric providers on evidence-based communication strategies for communicating with 
caregivers about the HPV vaccine. The provider communication education session was verbally 
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given with the aid of a PowerPoint presentation (Appendix D) on January 14, 2019.  Data for 
HPV vaccine initiation rates were examined 6 weeks prior to session implementation and 
compared with 6 weeks post session implementation.   
Quality measure reports were generated to examine HPV initiation vaccination rates (%) 
for each provider using the patient parameters of 11 to 18 years of age.  The quality measure 
report identifies Provider A, B, C, D, the number of patients seen in the age 11-18 years 
parameter and the number of patients that received their HPV vaccine that is given a “satisfied” 
status to qualify for HPV vaccine initiation. A satisfied status indicates documentation of HPV 
vaccination discussion.  An overall HPV initiation vaccination rate (%) is assigned to each 
provider 6 weeks prior to intervention implementation and 6 weeks post implementation.  The 
change in HPV vaccination rate were calculated for each provider by comparing post-
intervention rate to pre-intervention rate.    
Weighted Satisfaction Rates  
Because each provider interacted with a different number of patients, the satisfaction 
scores were required to be weighted to reflect the true impact of each provider.  To calculate the 
satisfaction rate for each provider, the number of patients determined to have satisfactory HPV 
interaction was divided by the total number of patient seen in each epoch (pre-implementation 
and post-implementation). The individual provider satisfaction score was then multiplied by the 
weight to determine a true rate related to the overall practice.  Overall, all providers (A, B, C, D) 
increased their HPV vaccination uptake rates individually and by an average of 3.7% for the 
primary care pediatric practice as a whole for patients 11-18 years in the 6 weeks post 
implementation of the provider communication education session.    
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Pre-Implementation Results 
 Table 1 reports data collected on HPV initiation vaccination rates for four providers 
(A,B,C,D) 6 weeks prior to and following the implementation of the provider education 
intervention.   The quality reporting system identified 1024 total patient records that were 
eligible, active, and met age criteria.  Between providers, the total patient counts ranged from 
108 to 610, with weighted pre-intervention satisfaction rates ranging from 44.43% to 59.30%.   
23 
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Table 1: Provider –specific satisfaction rates (SR) before and after the communication strategy implementation in the clinical site 
 
Provider  Pre-Program Count Pre-SR % Post-Program Count Post –SR% Change in Satisfaction (%)________ 
 
A 
 Total Patients  108    108 
  Needs Data  48    44 
  Satisfied  60 55.55%  64  59.26%  + 3.71% 
  Weight (10.54) SR  5.85     6.25 
B 
 Total Patients  134    134 
  Needs Data  62    55 
  Satisfied  72 53.73%  79  58.96%  + 5.23% 
  Weighted (13.08)SR  7.03     7.71 
C 
 Total Patients  172    172 
  Needs Data  70    60 
  Satisfied  102 59.30%  108  62.79%  + 4.41% 
  Weighted (16.79) SR% 9.96     10.54 
D 
 Total Patients  610    610 
  Needs Data  339    318 
  Satisfied  271 44.43%  292  47.86%  + 8.60% 
  Weighted (59.57) SR   26.47     28.51_____________________________________ 
 
Overall Total Patients  1024    1024 
Overall Satisfaction Rates   49.31%    53.01%  + 3.7% 
____________________________________________________________________________________________________________ 
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2. Post-Implementation Results 
 Also reported in Table 1 is the 6 weeks post- implementation data. The quality reporting 
system identified 1024 total patient records there were eligible, active, and met age criteria.  
Between providers, the total patient counts ranged from 108 to 610 (consistent with total patient 
counts in the pre-intervention count), with weighted post-intervention satisfaction rates ranging 
from 47.86% to 62.78%.  To determine change in satisfaction score, each provider’s pre-
intervention satisfaction percentage was subtracted from their post-intervention satisfaction 
percentage to generate the change in satisfaction score.  The change in satisfaction increased across 
all providers ranging from 3.71% to 8.60%.  
3. Discussion and Conclusions 
 Pediatric patients remain a vulnerable population to the most common sexually  
transmitted infection in the United States, the Human Papilloma Virus (HPV).  Understanding 
and addressing parental concerns, being knowledgeable about HPV vaccine and disease, 
recommending the HPV vaccine with the same strength as Tdap and Menactra (meningococcal), 
emphasizing cancer prevention, and delivering a consistent message to parents among providers 
according to evidence-based literature findings has shown to be reliable elements to incorporate 
into provider education to increase an almost 100% effective cancer prevention vaccine (Cates et 
al., 2018).   
Overall, the DNP project pilot tested a provider education session aimed at quality 
improvement for evidence-based communication strategies for improving HPV vaccine uptake, 
and a limited evaluation of HPV vaccine initiation rates was conducted for four providers in a 
specific pediatric primary care practice. The intervention was found to be a cost-effective and 
time-sensitive intervention to promote improved HPV vaccination rates. Overall, the average rate 
Running head: HPV VACCINATION PROVIDER EDUCATION 25 
 
increased from 49.31% to 53.01%. Data was successfully collected, analyzed, and evaluated 6 
weeks prior to and post implementation of provider communication education pilot session for a 
specific pediatric primary care practice.  Vaccination rates for the state of Ohio and nationally 
were gathered successfully as benchmark data.  The provider communication education pilot 
session was developed using quality indicators and evidence-based literature reflecting provider 
recommendations and communication behaviors that consistently influence compliance.   
Findings suggest that provider communication behaviors can be positively influenced and 
improved using key elements to create increased HPV vaccination initiation rates.  Future 
endeavors include re-delivery of the provider education intervention on a regular basis to be 
determined.  Interventions to promote HPV vaccinations are planned with the goal of an 80% 
vaccination rate.  
4. Limitations 
 The provider communication education session is a clinically feasible intervention that is 
cost-effective, sensitive to provider obligations, less than one hour, and directed at providers in a  
straight-forward manner in how and why increased HPV vaccine uptake is vital.  The pediatric 
primary care intervention site and healthcare organization was supportive of the desired outcome  
of improved vaccination rates and vested in the success of the intervention which aided in  
statistical data collection and quality measurements.  Potential barriers for future interventions  
include time and varying schedules, perceived benefit, and personal views of the HPV  
vaccination.    
 Limitations in this project included the time constraints of post intervention data.  Longer 
time frames for data collection would be preferred for future evaluations to better ascertain the  
provider vaccination rate and data trends.  According to the US Preventative Services Task Force  
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(2017), quantifying the impact and benefit from a primary care intervention may take years to  
achieve.  Thus, continued data collection at 6 months and yearly to provide further data on  
vaccination initiation rates would be advised.  Furthermore, this project addresses only vaccine  
initiation rates; data collection on HPV vaccine series completion would also be beneficial when  
examining vaccine rate trends, but was not plausible secondary to time limitations for this  
project. However, newer evidence demonstrates that even one dose of HPV vaccine may be 
effective in preventing cancer. Therefore, it may be assumed that even the children who do not 
complete the series may still receive benefit from one dose.  
Section Five: Recommendations and Implications for Practice 
1. Project Summary 
 A provider communication education session was implemented in a pediatric  
primary care practice using evidence-based strategies that fuses information on HPV disease,  
HPV vaccination, parental communication strategies, high-quality language, cancer prevention, 
and supporting statistics.  Provider vaccination initiation rates were examined 6 weeks prior to 
the education session implementation and 6 weeks post education session implementation to 
evaluate HPV vaccine initiation rate uptake.  Quality Management Reports were created for each 
provider for HPV vaccination initiation rates for ages 11-18 years for the 6 weeks pre and post 
intervention implementation.  Findings for this project support the current research that provider 
communication behaviors and recommendations consistently guide compliance in adolescents 
receiving the HPV vaccination.      
2. Implications for Practice 
 An evidence-based quality improvement project, can provide the advanced practice nurse 
the an opportunity to use acquired knowledge and demonstrate leadership skills to assuredly  
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impact pediatric health outcomes and status.  This provider communication education session  
was implemented to increase provider knowledge for discussions with patients with the goal to 
increase HPV vaccination rate.  This project examined the application of evidence-based 
research, health plan leadership and change, quality indicators, and evidence analysis and 
evaluation (DNP Essential I, II, III).  Future evaluation on parental satisfaction with provider 
guidance, provider recommendation quality improvement, parental confidence in vaccines, and 
provider-parent relationship quality will provide insight to adjusting HPV vaccine dialogue, as 
quality improvement is a continuous process.  
The project serves as a center-specific health care policy redesign proponent in the 
advocacy of improved HPV vaccination rates to decrease HPV-related cancers, injurious 
sequelae, and local and national health care costs (DNP Essential V).  It is also an example of 
interprofessional collaboration among providers and healthcare systems as adoption of improved 
communication behaviors impact parental decisions to vaccinate their children against HPV, thus 
improving community and population health outcomes and quality of care (DNP Essential VI, 
VII).  DNP prepared advanced practice nurses are integral change agents  in the design of 
intervention, implementation, and evaluation of HPV provider communication education 
sessions, educating and guiding providers, supporting staff, and administration to achieve ideal 
patient and health outcomes (DNP Essential VIII).   
 This project reflected the internal evidence collected in a real-life setting, supported by 
the literature that HPV vaccination rates are not progressing and a provider communication 
education session is a successful intervention driven by evidence to increase HPV vaccination  
rates.  Recommendations for the practice intervention site include continued use of an evidence-
based provider education intervention in the promotion of HPV vaccination and ongoing 
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surveillance of HPV vaccination trends and rates.  It is recommended that the HPV provider 
communication education session’s success on increasing HPV vaccination uptake be circulated 
to the health care organization’s leadership and administration to further the dissemination of 
results and implementation in other healthcare settings, such as other pediatric or family practice 
primary care offices.  Lastly, it is recommended further evaluation on parental satisfaction with 
provider guidance, provider recommendation quality improvement, parental confidence in 
vaccines, provider-parent relationship quality, and staying abreast of developing evidence-based 
literature will provide insight to HPV vaccine dialogue adjustments, as quality improvement is a 
sustained process.   
3. Methods of Dissemination 
 Dissemination methods include: 1. Presentation of data findings and results for discussion  
to the pediatric primary care intervention site and 2. Presentation of data findings and results to  
specific medical group as well as the system-wide group provides an opportunity for the larger 
umbrella healthcare organization. 3. Publication.   
The pediatric primary care intervention site is an appropriate dissemination of findings 
and performance based feedback to fully understand the impact we, as healthcare providers, can 
have on patient health outcomes and learning from evidence-based best practices.  The system 
wide presentation of findings and results would be valuable to Providence Medical Group 
because it is composed mostly of family practice groups that would benefit from the HPV 
vaccine information, both as primary care and as the HPV vaccination has now been approved 
for ages 9-45 years according to the FDA (2018).   
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APPENDIX A  
SYNTHESIS TABLE 
Study/ Author Year # Participants 







Major Finding that address 
your question 
Dempsey, A. et 







median age 12.6 
years RCT 
Info sheets, parent ed 
website, disease images, 
communication 
training 
Key factor influencing HPV 
vaccination is whether and how 
HCP recommends it.  
Hudson, S. et al. 
Vaccine, 34, 




nurses Qualitative  Analyzation 
Communication was a factor that 
identified higher performer HPV 
vaccine rates.  
Rand, C. et al. 
Pediatrics, 141, 





learning collaborative calls  
Training on the delivery of a 
strong provider recommendation 
and performance feedback can 
substantially increase captured 
HPV vaccination opportunities.  
Clark, S. et al. 
Clinical 
Pediatrics, 55, 




Parent of one 
more children 





Survey on provider 
interactions 
Study found that provider 
statements with a strong 
recommendation and a specific 
age to begin HPV series was 











methods Interview and survey 
Communication methods, social 
media, and health system 
improvement can increase HPV 
compliance. 




Gamble, H. et 





to receive HPV 
vaccine unknown 
Lit. 
Review Receiving HPV vaccine.  
Pediatrician attitudes and 
intentions, HPV knowledge, 
beliefs about pt sexual hx, 
comfort of disc. sexual behaviors, 
and beliefs on the impact of HPV 
vaccine promote successful 
vaccine delivery.  







At least 100 11 
and 12 yo who’d 
not completed 
HPV vaccine.  
Meta-
analysis 
Received HPV vaccine 
initiation and completion 
over three 9 mo periods. 
Protect Them program.   
17% increase was seen in 
practices with intervention 
implemented in initiation and 
completion of HPV vaccine 
series.  
Fairbrother, G. 




members  unknown 
Meta-
analysis 
Reviewed concerns about 
immunization schedule.  
IOM suggested providers 
consider communication training 
to improve patient-provider 
communications around 
immunization issues, as parents 
rely on their professional advice.  
McRee, A. and 
Gilkey, M. Jnl 
of Ped Health, 

















parental hesitancy.  
HPV vaccine compliance stresses 
the importance of increasing the 
frequency and quality of 
recommendations. HCP role is 








literature on unknown 
Lit. 
Review 
Receiving the HPV 
vaccination.  
HCPs must be well-informed 
about current guidelines and 
safety to communicate with 
parents about HPV vaccine. HCP 
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HPV attitudes 
and uptake.  
recommendation is among the 
most important determinants of 
HPV vaccination.  










verification.   
Caretakers of 13 
to 17 yo 
adolescents Descriptive 
Provider recommendation of 
HPV vaccination.  
Efficient communication styles 
were rarely used but highly 
effective for recommending the 
HPV vaccine.  








medicine unknown Descriptive 
Recommending adolescent 
vaccinations in a 
communication context.  
Physicians chose to discuss HPV 
vaccine last; communication 
strategies are needed to support 
recommendations with greater 
confidence and efficiency.  








(13-17 yo teens) 
Parental beliefs 
data on vaccines Descriptive Received HPV vaccination.  
HPV vaccine coverage can be 
increased through HCP talking 
about the vaccine, giving parents 
time to discuss vaccine, and by 
making a strong recommendation 
for the HPV.  
Gilkey, M. et al. 
Vaccine, 34, 
1187-1192. 2016 
1495 parents of 
11-17 yo 
adolescents 
Which types of 
recommendations 
are most 
influential  RCT 
Recommending the HPV 
vaccination.  
Intervention is needed to improve 
not only whether, but how 
providers recommend HPV 
vaccination for adolescents.  
Finney, L. et al. 
Vaccine, 35, 
164-169. 2017 
280 primary care 
clinicians 
looking at HPV 
completion 





parental barriers Descriptive 
HPV vaccination series 
completion, survey. 
Greater knowledge of HPV and 
HPV vaccination was associated 
with higher rates of HPV 
vaccination initiation and 
completion.  
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of boys and girls 
11-21 years old Descriptive 
QI incentives, repeated 
contacts, education, and 
individualized feedback.  
Interventions improved 
vaccination rates and had 
potential to produce sustained 
HPV vaccination rates. 
Kornides, M. et 
al. Vaccine, 36, 
2637-2642. 2018 




Parents who had 
discussed the 
HPV vaccine 
with HCP at least 
once Descriptive 
Provider communication 
satisfaction association with 
HCP communication and 
HPV vaccination.  
High-quality provider 
recommendation includes strong 
endorsement for same-day 
vaccination and emphasis on 
cancer prevention. Parental 
satisfaction with HCP counseling 
is also important with HPV 
vaccination initiation and 
completion. 
Groom, H. et al. 
Jrnl of Public 
Health Mngt 
and Practice, 23, 
589-592. 2017 








male and female 
adolescents Qualitative 
System-wide assessment 
and feedback intervention, 
education session including 




Working collaboratively with 
health care system and state 
partners to develop an 
intervention for population 













HPV vaccination regimens 
for teenagers.  
Ethical issues  include people 
abstaining from sexual activity, 
does vaccine increase sexual 
relations, research costs, and 
practical aspects of 
recommending HPV vaccine to 
parents and patients. 
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Reno, J. et al. 
Jrnl of Health 
Communication, 
23, 313-320. 2018 
Healthcare 
providers and 















< 80%, and offer 
HPV vaccine.  RCT 
Motivational Interviewing 
included in communication 
HCP training.  
Intervention improved providers’ 
communication with HPV-
hesitant parents improved HPV 
vaccine acceptance.  
 
Legend example: D=depression; Q=quasi-experimental design; RCT=randomized controlled trial; CC=case control; CD=cohort 
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